Alzheimer’s drug from Eisai, Biogen shows promise in large trial
admin Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read Moreindustrial news
Airport and airline workers speak out worldwide about ‘ridiculous’ conditions
Airport and airline workers staged demonstrations at airports across the U.S. and abroad Tuesday, protesting…
Read MoreTyson Foods shuffles leadership team, names new CFO
Tyson Foods Inc. TSN, -0.57% on Tuesday shuffled its leadership team. The meat processor said…
Read MoreBlackberry stock slips even as results come in above expectations
BlackBerry Ltd. shares slipped in the extended session Tuesday even after the cybersecurity and Internet-of-Things…
Read MoreBig banks to pay nearly $2 billion for ‘widespread and longstanding failures’ in keeping text-message records
Nearly a dozen financial institutions agreed to pay more than $1.8 billion collectively for failing…
Read MoreCathie Wood’s ARK creates venture capital fund open to individual investors
Cathie Wood’s Ark Investment Management is giving ordinary investors access to a venture capital fund…
Read MoreCal-Maine says avian flu could continue to hit egg supplies after this year
Shares of Cal-Maine Foods Inc. edged lower in the extended session Tuesday after the largest…
Read More‘The motivation was greed’: Ex-Nigerian official gets 5 years for stealing US disaster funds
A former government official in Nigeria has been sentenced to five years in a U.S.…
Read MoreCSX, Norfolk Southern stocks sink to near 2-year lows after UBS downgrades, citing a ‘deteriorating’ outlook
Shares of CSX Corp. and Norfolk Southern Corp. both sank toward the lowest levels in…
Read More
Verizon hasn’t been a very defensive stock lately, but here’s how things could flip
Telecommunications stocks are said to be defensive, but Credit Suisse analyst Douglas Mitchelson wrote that…
Read More